Tyratech (DI) Share Discussion Threads

[mudbath] 04/3/2017 09:43

I mentioned to corrientes that a lot was "going on in the background" at Tyratech.
Hopefully we investors will be provided with more detail come the prelims.

In the meantime the following solicitation does indicate that TYRU are indeed currently seeking to release some value from their non core technology portfolio.Responses are needed before the end of this month !

"Mondelēz International is seeking to outlicense a proprietary breakthrough technology in the area of intestinal parasite infection reduction and prevention jointly developed by Mondelēz International and TyraTech. The technology is a proprietary combination of a parasite prevention technology and a novel delivery system to insure optimal delivery and effectiveness.

The technology is based on a proprietary synergistic blend of natural, plant-based essential oils microencapsulated in a delivery system that has the potential to be used as a food ingredient and formulated into a great tasting food or beverage or as a nutriceutical ingredient for human and animal health applications. The technology releases in the intestine where the parasites reside. The result is a significant reduction in the worm burden, killing off a significant percentage of the worms and eggs.

Background
Intestinal parasites, Helminths, are a significant public health issue in developing countries where there are under-developed sanitation systems and potentially substandard housing conditions. These intestinal parasites are worm-like organisms that live & feed off living hosts, disrupting their hosts’ nutrient absorption & causing weakness and disease. These parasites disproportionately afflict children, cause a number of serious health concerns & contribute to cycles of poverty. School age children are particularly susceptible to contracting parasites, resulting in malnutrition, vomiting, anemia, insomnia, immune suppression and delayed intellectual development. Long term physical and cognitive damage can be caused by these parasites and in extreme cases can be fatal.
Current synthetic drug solutions are sub-optimal, with unpleasant side effects, issues with the development of resistance and are not preventative. Animal studies suggest drugs can be embryotoxic and teratogenic, raising safety concerns for children and pregnant women.
Mondelēz International and TyraTech have invested significant time and effort into the collaborative development of a parasite prevention technology targeted to reduce the impact of these intestinal parasites as a public health issue. The high value technology solution developed by Mondelēz International and TyraTech is designed to be safe, natural and non-toxic. It effectively kills intestinal parasites and is deployable as a daily maintenance solution through several platforms and has potential applications for both human and animal health applications..

Key Success Criteria
The following represents the scope of IP available for licensing:

Compositions and Methods for Controlling Insects
(US 7,541,155 and other countries)
Compositions and Methods for Controlling Insects
(US 8,685,471 and other countries)
Compositions and Methods for Controlling Insects Related to the Octopamine Receptor
(US 7,622,269 and other countries)
Pest Control Using Natural Pest Control Agent Blends
(US 8,501,247 and other countries)
Synergistic Antiparasitic Compositioions and Screening Methods
(WO2009/086471 and other countries)
Pest Control Compositions and Methods
(US 8,691,256 and other countries)
Antiparasitic Compositions and Methods
(US 2015/0150838 )
Novel Preparation of Enteric Release System
(US 8,859,003 and other countries)
Novel Preparation of Enteric Release System
(US 8,765,030 and other countries)
Delivery of Functional Compounds
(US 2010/0310666A1 and other countries)
Enteric Delivery of Functional Ingredients Suitable for Hot Comestible
(US 8,859,005 and other countries)


Preferred Collaboration types
Joint Development Technology Licensing

Items to be submitted
How to Respond:
We are looking for concise, non-confidential expressions of interest.

To Respond, please use the Respond button located at the end of this page.


Point of Contact Stephen Clulow

Area of Interest
Medical Products & Services Medical Equipment & Supplies

Organization Mondelēz International

Due Date March 24, 2017"

INTERESTING.

[mudbath] 03/3/2017 14:39

Said like a true punter gilesgraves.
You will feel even more strongly about the omission once the shares double over coming months.

[gilesgraves] 03/3/2017 14:24

I wish Id have bought a lot more under 2p

[professor pettigrew] 03/3/2017 11:42

Many congratulations "michales" - you've managed to haul these back to the princely sum of 2p.

[michaelsadvfn] 03/3/2017 09:12

Ignore the troll giles, and don't give him the satisfaction of a response. He's just looking for a response so he can respond with more rubbish to ruin the thread.

It's what he does.

[gilesgraves] 03/3/2017 09:04

What is not delectable though is your rectal fistitude. Its really sad the way you chase michaels with these trolling taunts.

[professor pettigrew] 02/3/2017 15:20

Tsk! Tsk! "michaels" Down again?

Pull yourself together man. Surely with your fiscal rectitude you can do better than this. Another 12% lost on top of all the broken promises you have made here over the years.

How much money have you lost your pilgrims now?

They'll be wanting your severed head on a plate next.

Mind, that'll be a delectable sight.

[mudbath] 02/3/2017 09:46

Maybe corrientes,yet I feel that if there is to be any jam,we will see it spread in 2017, for there is much happening with TYRU as we speak.

[corrientes] 02/3/2017 09:42

Two or three masochists here. There's lots of other companies worthy or more attention. Don't doubt that in a couple of years' time, it'll be still be jam tomorrow.

[michaelsadvfn] 02/3/2017 09:38

Clearly someone wanted to sell 300k ...and have done so. More shares to be had at under 2p by the look of it.

Can't blame folk for losing patience. Testing times.

[mudbath] 02/3/2017 09:32

It looks as though the MMs are maneuvering the share price towards a mark down.
Let's hope it proves small and temporary.

[professor pettigrew] 28/2/2017 16:52

I have to laugh "michaels".

You came on the Xtract Resouces (XTR) thread, and showed your usual immaturity by trashing not just me but the thread.

Now, they've just released a stonking RNS and are set to soar. If you understand anything about the gold market you might like to give it a read tonight.

You, in the meantime are stuck in this rubbish and have also lost your pilgrims a large amount too.

Not too late for your to repent though my brotherly friend, and get into XTR first thing.

I have to laugh though "michaels".

[clocktower] 28/2/2017 16:13

"mudbath13 Feb '17 - 09:44 - 1432 of 1526 0 0
Thanks Nobbygnome.
Whilst I do not have access to Level 2"

Catching up on the thread, I have a problem believing the above post, in view of comments made over the years on other threads,however maybe have not paid for L2 recently or had access at the time mud. Maybe a Nasty Bug causing them problem. :-)

[mudbath] 28/2/2017 15:23

275,000 TYRU shares sold so far today,yet the MMs are still currently prepared to take a further 250,000 within the spread.
Maybe then not as weak a market as we have seen in recent months when similar selling would have see the bid reduced.
Roll on some positive news !

[michaelsadvfn] 28/2/2017 08:50

In the absence of news it's looking like it will be April before we see any action here.

No trades for 4 days bar a couple of tiddlers says enough.

[mudbath] 27/2/2017 12:56

Why the Animal Health Industry is your next big investment opportunity.
----------------------------------------------------------------------
Over the last few years promising new startups are emerging in the animal health industry. Ranging from new vaccines for cattle to treatments for domestic pets this growing industry is set to boom in 2016 and beyond.

According to Vetnosis STORM FORECASTS, the global animal health market is already valued at $24 billion and is expected to enjoy a continual annual growth rate of 3% to 2020. It is not surprising, then, that existing pharmaceutical firms and increasingly venture capitalist and private equity firms are now turning their attention to companies developing treatments, such as animal health therapeutics, for both companion pets and industrial animals.

"Source:-Animal Health Europe Ltd."

[michaelsadvfn] 24/2/2017 08:29

With or without a chart we come to the same conclusion ;-)

[mudbath] 23/2/2017 19:24

Each of your statements is partly correct imo.
I too could talk you through each machination in the share price over the past three years.
Apples and oranges ?
Both are citrus,tangy,juicy,round with peel and pips.
Supposedly good for you as well!

[michaelsadvfn] 23/2/2017 19:01

I could talk you through every major movement on that chart but it would take so long I'll give that a miss. I'm not a fan of charts for a number of reasons.

I'll say one thing though, this share would never have hit 20p+ had there not been an article in the Daily Mail about Tyratech & Vamousse and had that article not been printed the chart would be COMPLETELY different.

The market cap was close to £40m at the top of that spike yet the company had virtually no income. No wonder the share price tumbled back to where it started. The line drawn from over 20p down through highs hit in 2016 are totally irrelevant; you cannot relate them. For a start there were 262m shares in existence at the start of 2014, in 2016 there were 367m so 5p in mid 2015 is totally different to the 5p hit in 2016 !

A chart based purely on market cap would be far more useful but that doesn't exist as far as I am aware because I once hunted for one with no luck. Comparing the Tyratech of 3 years ago to today's Tyratech is like comparing apples and oranges.

Just my tuppence worth.

[mudbath] 23/2/2017 17:17

BIKWIK makes an interesting point about the TYRU share price hitting the low point of its annual cycle each December.Although his chart only covers three years,a similar pattern had occurred previously.

The share price upturns were seen starting in late February through until mid May with a steady decline setting in thereafter.

If this trend is continued in 2017 we could be looking at a rising share price at any moment.
A positive news flow from Tyratech could then ensure further progress throughout the full year.

[michaelsadvfn] 23/2/2017 13:37

Thanks for that BIKWIK.

Volume is key and there's not enough of it to take us in either direction at the moment.

Hopefully management will have something positive to say when the results are published towards the end of April, then we may see some real volume.

[mudbath] 23/2/2017 13:14

My thanks to BIKWIK for posting the above chart together with his interesting observations.From previous experience I can say that his opinions often prove to have a prescient quality.

[bikwik] 23/2/2017 13:09

free stock charts from uk.advfn.com


There are three clear cycles on the chart, each about a year in duration. The cycles end either at or towards the end of each year. Given that the trend in these three cycles is down one could be forgiven for expecting the next cycle to be down as well. Given the angle of overall descent that would suggest the share price was destined to reach zero or the company goes bust.

However, don't panic! After the third cycle a change often occurs. So, as the company looks pretty healthy (cash of $1.7m plus at the int stage...I checked), though maybe it has eaten into that a little bit by the Dec 2016 year end as its not making a profit yet. I digress from the chart! So, it seems to me that the recent lows - all six of them! - look like the bottom. We should be commencing an upswing phase. At this stage it looks early days and 2p, maybe just under, could be retested, though encouragingly the volume last week on the move up to 2.5p was the highest in over 5 months.

There is an important downtrend line shown - currently around 3p. This needs to be cleared to suggest the trend was starting to turn to the upside and thus be sustainable. The 40 week (200 day) moving average - currently falling also needs to start rising to confirm such an upward shift was occurring. Clearing the resistance at 3.50p would be excellent news but I think you may have to be patient a bit longer, though as I said I think the low is in. Good luck.